CARA THERAPEUTICS INC (CARA) Stock Balance Sheet
NASDAQ:CARA - Nasdaq - US1407551092 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 37.06M | 51.77M | 63.70M | 13.50M | 31.70M | |||
| Marketable Securities | 4.97M | 48.98M | 81.70M | 153.60M | 149.20M | |||
| Receivables | 1.37M | 4.02M | 4.50M | 1.20M | 2.10M | |||
| Inventories | 625.00K | 2.82M | 2.40M | 2.60M | N/A | |||
| Other Current Assets | 3.88M | 8.56M | 16.70M | 2.50M | 12.10M | |||
| Total Current Assets | 47.91M | 116.16M | 168.90M | 173.30M | 195.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.42M | 8.19M | 2.00M | 3.60M | 5.10M | |||
| Investments And Advances | N/A | 0.00 | 11.40M | 69.80M | 70.60M | |||
| Other Non-Current Assets | N/A | 1.50M | 0.00 | 400.00K | 400.00K | |||
| Total Non-Current Assets | 3.42M | 9.69M | 13.30M | 73.80M | 76.10M | |||
| TOTAL ASSETS | 51.33M | 125.84M | 182.20M | 247.10M | 271.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.50M | 14.01M | 13.90M | 12.00M | 13.60M | |||
| Accounts Payable | 2.54M | 11.58M | 9.60M | 5.60M | 4.90M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 10.04M | 25.59M | 23.50M | 17.60M | 18.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 40.58M | 43.17M | 0.00 | 1.90M | 3.70M | |||
| Total Non-Current Liabilities | 40.58M | 43.17M | 0.00 | 1.90M | 3.70M | |||
| TOTAL LIABILITIES | 50.62M | 68.76M | 23.50M | 19.50M | 22.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -747.93M | -684.75M | -566.20M | -480.80M | -392.30M | |||
| Additional Paid In Capital | 748.61M | 742.04M | 726.60M | 708.60M | 641.20M | |||
| Common Shares | 54.00K | 54.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -25.00K | -260.00K | -1.70M | -400.00K | 100.00K | |||
| Shares Outstanding | 4.57M | 4.54M | 53.80M | 53.50M | 49.90M | |||
| Tangible Book Value per Share | 0.15 | 12.57 | 2.95 | 4.25 | 4.99 | |||
| Total Shareholders' Equity | 707.00K | 57.09M | 158.80M | 227.50M | 249.00M | |||
| TOTAL LIABILITIES AND EQUITY | 51.33M | 125.84M | 182.20M | 247.10M | 271.20M | |||
| Statistics | ||||||||
| Current Ratio | 4.77 | 4.54 | 7.19 | 9.85 | 10.55 | |||
| Return On Assets (ROA) | -186.10% | -94.17% | -46.93% | -35.77% | 3.10% | |||
| Return On Equity (ROE) | -13511.32% | -207.61% | -53.84% | -38.86% | 3.37% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 1.69% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 5.94% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | 5.94% | |||
All data in USD , ROIC based on taxRate of 0.21